2013年3月3日

癌症病患冷凍保存部分睪丸或卵巢組織是未來趨勢

目前無有效藥物防止睪丸或卵巢組織於化療或放射治療過程之受到傷害
癌症病患事先冷凍保存部分睪丸或卵巢組織是未來必須積極考慮之方向

http://humrep.oxfordjournals.org/content/26/4/737.full

Options for fertility preservation in prepubertal boys

Abstract

BACKGROUND Fertility in adult life may be severely impaired by gonadotoxic therapies. For young boys who do not yet produce spermatozoa, cryopreservation of immature testicular tissue (ITT) is an option to preserve their fertility, albeit still experimental. This paper covers current options for ITT cryopreservation and fertility restoration.
METHODS Relevant studies were identified by an extensive Medline search of English and French language articles. Search terms were: gonadotoxicity, cytoprotection, cryopreservation, ITT, spermatogonia, testicular transplantation, testicular grafting and in vitro maturation (IVM).
RESULTS Although no effective gonadoprotective drug is yet available forin vivo spermatogonial stem cell protection in humans, current evidence supports the feasibility of ITT cryopreservation before gonadotoxic treatment with a view to fertility preservation. Controlled slow freezing with dimethyl sulfoxide allows survival and proliferation of human spermatogonia after xenotransplantation, but only partial differentiation. Animal data look promising, since healthy offsprings have been obtained after transplantation of frozen testicular cell suspensions or tissue pieces. However, none of the fertility restoration options from frozen tissue, i.e. cell suspension transplantation, tissue grafting and IVM have proved efficient and safe in humans as yet.
CONCLUSION While additional evidence is required to define optimal conditions for ITT cryopreservation with a view to transplantation or IVM, the putative indications for such techniques, as well as their limitations according to disease, are outlined.

Key words

沒有留言:

張貼留言